Bloating After Menopause: What the Gut Bacteria Research Shows

• Is bloating after menopause really this common?
• Why does the gut change shape after menopause?
• What does shilajit's humic acid actually do to gut bacteria?
• Do the bacteria that rise actually relieve digestive symptoms?
• How does this compare with the usual bloating advice?
• What else genuinely helps day to day?
• Common questions about bloating after menopause

Is bloating after menopause really this common?

Most women expect hot flashes and sleep trouble at menopause. Almost nobody is warned about the gut.

A survey of 564 women aged 44 to 73, presented at The Menopause Society's 2025 annual meeting, found 94% of them reported digestive health symptoms. Bloating led the list at 77%, followed by constipation at 54%, stomach pain at 50%, and acid reflux at 49%. Most striking, 82% of the women said their symptoms either began or clearly worsened during perimenopause or menopause, not before. Despite how common this was, only 33% of the women with real gut trouble had ever received a formal diagnosis for it.

That gap between how many women live with this and how few get an explanation is the reason this article exists.

A peer-reviewed review backs up the survey

A 2021 narrative review in the journal Women's Midlife Health, by researchers Pei-Lin Yang, Margaret Heitkemper, and Kendra Kamp, examined why midlife women seek care for gastrointestinal symptoms and irritable bowel syndrome so much more often than younger women. The review's own analysis found that lower estrogen levels were independently predictive of increased abdominal pain severity over time. Stress, sleep disruption, and the gut microbiome itself all played supporting roles, but estrogen came out as a genuine driver, not a bystander.

Why does the gut change shape after menopause?

The gut is not a passive digestive tube. It hosts trillions of bacteria that break down food, train the immune system, and, less widely known, help recycle the body's own estrogen. One collection of these microbes, sometimes called the estrobolome, produces an enzyme that unlocks estrogen so the body can reuse it rather than simply excreting it.

When estrogen falls at menopause, that recycling loop has less to work with, and the bacterial community built around it reorganizes. The relationship runs in both directions. Estrogen shapes which bacterial species thrive, and those bacteria in turn influence how much estrogen circulates. When one side of that loop weakens, the whole system feels it, and digestion is one of the first places that shows up.

• Bloating, cramping, and irregularity often get blamed on diet or stress alone
• The underlying bacterial shift can be present even when nothing in the diet has changed
• Symptoms tend to cluster with other menopause changes rather than appearing in isolation
• The shift is gradual, which is part of why it goes unexplained for so long

What does shilajit's humic acid actually do to gut bacteria?

Shilajit is a mineral-rich resin that forms over centuries as plant matter breaks down under pressure high in the Altai mountains. Its two defining organic-acid families are fulvic acid, the smaller and more water-soluble compound, and humic acid, a larger, related molecule from the same carbon-based source.

The most direct human evidence on the gut comes from a trial by researcher Alexander Swidsinski and colleagues, published in the World Journal of Gastroenterology. Fourteen healthy adult volunteers took an oral humic acid extract for 45 days.

• Total concentration of existing gut bacteria rose from a 20 percent increase at day 10 to a 30 percent increase by day 31, holding through day 45
• Twenty-four of the 35 bacterial groups measured increased in concentration
• Each person's individual microbial profile stayed recognizably their own, and overall diversity remained stable
• The researchers described the effect as a potential alternative to probiotics or even fecal microbiota transplantation

This is a different mechanism than a probiotic capsule

It did not introduce new species or wipe out anything already present. It made the bacteria a person already carried more abundant, which is a fundamentally different approach than adding outside strains and hoping they survive stomach acid long enough to colonize.

Separate laboratory research on fulvic acid specifically found it stimulated growth of Lactobacillus and beneficial Clostridia species in vitro, while a 2018 review of fulvic acid's broader effects found it reduces TNF-alpha, an inflammatory marker connected to digestive discomfort. Neither of those two findings has been confirmed in a dedicated human trial. Both stay flagged as laboratory and review-level evidence, not proven human outcomes.

Do the bacteria that rise actually relieve digestive symptoms?

This is the question that makes the humic acid trial worth more than a curiosity, and it is also where the honesty has to be sharpest.

The 45-day trial measured bacterial counts, not symptoms. It did not ask whether any volunteer felt less bloated. But a separate body of human research has tested what happens when the same bacterial groups, Bifidobacterium, Lactobacillus, and the SCFA-producing species that generate butyrate, are raised in people who already have IBS-type symptoms.

• A randomized controlled trial of 443 IBS patients, published in The Lancet, found a specific Bifidobacterium strain eased abdominal pain, bloating, distension, and urgency significantly better than placebo
• A separate randomized trial found a different Lactobacillus strain reduced diarrhea-type IBS symptoms, including less pain and fewer bathroom trips
• Two 2025 randomized trials found oral butyrate brought real relief from cramping and pain in IBS patients, with beneficial SCFA-making bacteria rising and inflammatory bacteria falling
• A 2025 meta-analysis pooling 76 randomized trials rated Lactobacillus and Bifidobacterium the most effective options overall for IBS relief, cutting abdominal pain and normalizing stool pattern, especially the diarrhea-predominant type

None of these trials tested shilajit. They tested the specific bacterial species and compounds that shilajit's humic acid has separately been shown, in human volunteers, to raise. That is a chain of two real findings, not one combined study, and the gap between them is the honest limit of what can be said today.

Why the chain still matters

A woman does not need every link in a mechanism proven in a single trial before the pattern is worth knowing. Raising Bifidobacterium and Lactobacillus concentrations is not a hypothetical goal. Multiple randomized trials already show what happens when those bacteria rise in people with real symptoms. What shilajit's own human trial adds is a plausible, non-probiotic way to raise them.

How does this compare with the usual bloating advice?

Most women reach for the same handful of fixes first, usually without much luck, because those fixes were never built for a bacterial-composition problem.

Neither column has been tested in postmenopausal women against bloating specifically in one combined trial. What the second column offers is a different mechanism worth understanding, not a replacement claim.

What else genuinely helps day to day?

A handful of habits support the same system these studies describe, independent of any supplement.

• Eat a wide variety of plant fiber sources, since bacterial diversity responds to dietary variety more than any single food
• Stay consistently hydrated, since water intake affects how efficiently the colon processes fiber
• Limit ultra-processed foods, which several studies associate with reduced bacterial diversity
• Get regular movement, since physical activity is independently linked to a more diverse gut microbiome
• Prioritize sleep, since disrupted sleep patterns have been shown to alter gut bacterial composition within days

Shilajit's fulvic and humic acid content is the mechanism behind the human gut research described above, and it is the core ingredient in Optimum Shilajit, sourced from the Altai mountains and third-party tested for purity on every batch. No trial has tested our specific formula on bloating or IBS symptoms directly. That is not a result the research has actually shown, so it does not get implied here.